Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 169
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04605094 | Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis | ||
| NCT06498128 | Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ® | ||
| NCT03369262 | PoC Study of OBE022 in Threatened Preterm Labour | ||
| NCT00660673 | Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease | ||
| NCT03464019 | Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). | ||
| NCT07377682 | Real-world Clinical Response to Trazodone in Italy, Poland, and Romania | ||
| NCT05985083 | A Study Of IMM47 In Subjects With Advanced Solid Tumors | ||
| NCT04718389 | A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype | ||
| NCT04907968 | Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer | ||
| NCT05310734 | PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies | ||
| NCT05731908 | A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems | ||
| NCT03193476 | Registry for Patients With X-Linked Hypophosphatemia | ||
| NCT03649152 | Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan | ||
| NCT05560646 | A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain | ||
| NCT04612725 | A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO) | ||
| NCT04368065 | COVID-19 Active Research Experience (CARE) | ||
| NCT04280029 | SELUTION SLR™ 014 In-stent Restenosis | ||
| NCT02734004 | A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. | ||
| NCT03956355 | Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001) | ||
| NCT04744363 | Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab) | ||
| NCT07525427 | Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis | ||
| NCT04091360 | A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease | ||
| NCT05551195 | [Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression] | ||
| NCT03544281 | To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) | ||
| NCT05663515 | A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs | ||
| NCT05414422 | A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD | ||
| NCT06412250 | A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry) | ||
| NCT07000110 | Anifrolumab Malignancy and Serious Infections Study | ||
| NCT06951867 | Tezspire Cardiac Events PASS | ||
| NCT03712345 | Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA | ||
| NCT02953652 | Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) | ||
| NCT03285672 | FP-101 for the Treatment of Hot Flashes in Postmenopausal Women | ||
| NCT04151342 | CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS) | ||
| NCT05782179 | Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants | ||
| NCT06799221 | Expanded Access Program for OOS Obe-cel | ||
| NCT04324437 | eRAPID: Online Symptom Reporting in Lung Cancer | ||
| NCT06938854 | Investigational Study of SWM-831 to Treat Moderate and Severely Calcified Femoropopliteal Arteries | ||
| NCT03628235 | HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States | ||
| NCT04625725 | Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult. | ||
| NCT03553108 | A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours. | ||
| NCT03233360 | Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry | ||
| NCT04840849 | Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults | ||
| NCT04143503 | Observational Cohort Study on the Use of Parenteral Nutrition and Clinical Outcomes in Adult Critically Ill Patients | ||
| NCT04123574 | A Pilot Study of BXCL701 in Patients With Pancreatic Cancer | ||
| NCT06973161 | ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors | ||
| NCT03994328 | An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD | ||
| NCT04877691 | Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus | ||
| NCT03983980 | Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002) | ||
| NCT03976518 | Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial) | ||
| NCT03583164 | Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options |
